Retroperitoneal Kitlelere Yaklaşım
Özet
Retroperitoneal (RP) kitleler, ürolojik ve ürolojik olmayan hastalıkların kesişim noktası olan bu anatomik bölgede nadir görülen ancak hayati öneme sahip tümörlerdir. Primer tümörler germ hücreli tümörler (GHT), lenfomalar ve sarkomlar olarak sınıflandırılırken, anatomik olarak böbrekler, üreterler, ana damarlar ve lumbosakral pleksus gibi yapılar bu alanda yer alır. Benign kitleler arasında; üreter obstrüksiyonuna yol açabilen idiyopatik retroperitoneal fibrozis, spontan kanamalar, leiomyomlar ve miyelolipomlar bulunur. Malign kitleler ise genellikle belirgin bir semptom vermeden büyük boyutlara (ortalama 15 cm) ulaşabilir. Tanı aşamasında tomografi (BT), MRG, PET BT gibi görüntüleme yöntemlerinin yanı sıra genç erkeklerde AFP ve B-HCG gibi laboratuvar tümör belirteçleri ve histopatolojik tanı için kor biyopsi kritik rol oynar. Tedavi stratejileri kitle tipine göre değişiklik gösterir: lenfomalarda birincil tedavi kemoterapiyken; liposarkom, leiomyosarkom ve fibrosarkom gibi retroperitoneal sarkomlarda temel hedef, nüks riskini azaltmak amacıyla tümörün ve etkilenen komşu organların negatif cerrahi sınır sağlanarak en bloc (bütünsel) olarak cerrahi rezeksiyonla çıkarılmasıdır.
Retroperitoneal (RP) masses are rare but critical tumors that arise in this anatomical zone, which serves as a common region for both urological and non-urological diseases. Primary tumors are classified as germ cell tumors (GCTs), lymphomas, and sarcomas, while the anatomical area primarily hosts the kidneys, ureters, major vessels, and lumbosacral plexuses. Benign masses include idiopathic retroperitoneal fibrosis, which can lead to ureteral obstruction, spontaneous hemorrhages, leiomyomas, and myelolipomas. On the other hand, malignant masses typically grow silently without causing symptoms until they reach substantial sizes, averaging around 15 cm. In the diagnostic phase, imaging modalities such as computed tomography (CT), MRI, and PET-CT play a vital role, along with laboratory tumor markers like AFP and B-HCG in young male patients, and core biopsy for precise histopathological identification. Treatment strategies vary significantly depending on the mass type: while chemotherapy is the primary choice for lymphomas, the main therapeutic goal for retroperitoneal sarcomas—such as liposarcoma, leiomyosarcoma, and fibrosarcoma—is comprehensive en bloc surgical resection of the tumor along with the affected adjacent organs to ensure negative margins and minimize the risk of local recurrence.
Referanslar
McDougal WS, MacDonell RC. Treatment of idiopathic retroperitoneal fibrosis by immunosuppression. J Urol 1991; 145:112 114
Dedeoglu F, Rose CD, Athreya BH, et al. Successful treatment of retroperitoneal fibrosis with tamoxifen in a child. J Rheumatol 2001; 28:1693– 1695
Decmann Á, Perge P, Tóth M, Igaz P. Adrenal myelolipoma: a comprehensive review. Endocrine. 2018 Jan;59(1):7-15
Fabre-Guillevin E, Coindre JM, Somerhausen Nde S, et al: Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas, Cancer 2006 106(12):2725–2733
Tzeng CW, Smith JK, Heslin MJ: Soft tissue sarcoma: preoperative and postoperative imaging for staging, Surg Oncol Clin N Am 2007 16(2):389–402
Schwarzbach MH, Dimitrakopoulou-Strauss A, Mechtersheimer G, et al: Assessment of soft tissue lesions suspicious for liposarcoma by F18-deoxyglucose (FDG) positron emission tomography (PET), Anticancer Res 2001 21(5):3609–3614
Tateishi U, Terauchi T, Inoue T, et al: Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: PET/CT, Abdom Imaging 2010 35(2):232–240
von Mehren M, Randall RL, Benjamin RS, et al: Soft tissue sarcoma, version 2. NCCN clinical practice guidelines in oncology, J Natl Compr Canc Netw 2018 16(5):536–563
Domanski HA: Fine-needle aspiration cytology of soft tissue lesions: diagnostic challenges, Diagn Cytopathol 2007 35(12):768–773
Ikoma N, Torres KE, Somaiah N, et al: Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes, Ann Surg Oncol 2015 22(4):1068–1072
Bokemeyer C, Nichols CR, Droz J-P, et al: Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis, J Clin Oncol 2002 20(7):1864–1873
Brown JA, Bihrle R, Foster RS: Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings, Urology 2008 71(5):911–914
Albany C, Einhorn LH: Extragonadal germ cell tumors: clinical presentation and management, Curr Opin Oncol 2013 25(3):261–265
Olimpiadi Y, Song S, Hu JS, et. al.: Contemporary management of retroperitoneal soft tissue sarcomas. Curr Oncol Rep 2015; 17: pp. 39.
Gronchi A, Miceli R, Allard MA, et. al.: Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Ann Surg Oncol 2015; 22: pp. 1447-1454.
Gronchi A, Strauss DC, Miceli R, et al: Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the Multi-institutional Collaborative RPS Working Group, Ann Surg 2016 263(5):1002–1009
Tan MC, Brennan MF, Kuk D, et al: Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma, Ann Surg 2016 263(3):593–600
Schaefer IM, Fletcher CD: Myxoid variant of so-called angiomatoid “malignant fibrous histiocytoma”: clinicopathologic characterization in a series of 21 cases, Am J Surg Pathol 2014 38(6):816–823
Yamaguchi S, Nagasawa H, Suzuki T, et al: Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years, Clin Oral Investig 2004 8(2):52–55,
